Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction

European Heart Journal

Volumn 32, Issue 13, 2011, Pages 1614-1621

  Barsheshet, Alon ^a   Moss, Arthur J ^a   Eldar, Michael ^b   Huang, David T ^a   Hall, W Jackson ^a   Klein, Helmut U ^a   McNitt, Scott ^a   Steinberg, Jonathan S ^c   Wilber, David J ^d   Zareba, Wojciech ^a   Goldenberg, Ilan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac resynchronization therapy; Heart failure; Myocardial infarction

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; DEFIBRILLATOR; FEMALE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 79960021781     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq392     Document Type: Article

References (23)

1. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD investigators. Circulation 1992;86: 431-438.
2. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) investigators. Circulation 1993;88:2277-2283. (Pubitemid 23326108)
3. Gaudron P, Kugler I, Hu K, Bauer W, Eilles C, Ertl G. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol 2001;38:33-40. (Pubitemid 32613825)
4. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling\concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 2000; 35:569-582. (Pubitemid 30167013)
5. Chan AK, Sanderson JE, Wang T, Lam W, Yip G, Wang M, Lam YY, Zhang Y, Yeung L, Wu EB, Chan WW, Wong JT, So N, Yu CM. Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure. J Am Coll Cardiol 2007;50:591-596. (Pubitemid 47199012)
6. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand heart failure research collaborative group. J Am Coll Cardiol 1997;29:1060-1066. (Pubitemid 27149582)
7. Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HB, Hildebrandt PR. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000; 36:2072-2080.
8. Tenenbaum A, Fisman EZ, Motro M. Toward a redefinition of ischemic cardio-myopathy: is it an indivisible entity? J Am Coll Cardiol 2002;40:205-206; author reply 206. (Pubitemid 34701396)
9. Atkinson JB, Virmani R. Congestive heart failure due to coronary artery disease without myocardial infarction: clinicopathologic description of an unusual cardio-myopathy. Hum Pathol 1989;20:1155-1162. (Pubitemid 20034144)
10. Carluccio E, Biagioli P, Alunni G, Murrone A, Giombolini C, Ragni T, Marino PN, Reboldi G, Ambrosio G. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol 2006;47: 969-977.
11. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463. (Pubitemid 41821197)
13. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81: 1161-1172. (Pubitemid 20119612)
14. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem 1992;267:10551-10560.
15. Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 1996;155:13-21. (Pubitemid 26038062)
16. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993;87:755-763. (Pubitemid 23070806)
17. St John Sutton M, Lee D, Rouleau JL, Goldman S, Plappert T, Braunwald E, Pfeffer MA. Left ventricular remodeling and ventricular arrhythmias after myocar-dial infarction. Circulation 2003;107:2577-2582. (Pubitemid 36628939)
18. Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, Burke M, Moss AJ. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109:1082-1084. (Pubitemid 38332609)
19. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-1523. (Pubitemid 23133095)
20. Fallavollita JA, Canty JM Jr. Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium. Am J Physiol Heart Circ Physiol 2002;282:H1370-H1379. (Pubitemid 34654890)
21. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardi-omyopathy for use in clinical research. J Am Coll Cardiol 2002;39:210-218. (Pubitemid 34084623)
22. Ypenburg C, Sieders A, Bleeker GB, Holman ER, van der Wall EE, Schalij MJ, Bax JJ. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. Am Heart J 2007;154: 1160-1165. (Pubitemid 350161774)
23. Ciampi Q, Pratali L, Citro R, Piacenti M, Villari B, Picano E. Identification of respon-ders to cardiac resynchronization therapy by contractile reserve during stress echo-cardiography. Eur J Heart Fail 2009;11:489-496.